225 related articles for article (PubMed ID: 1983054)
1. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule.
Strein K; Sponer G
Z Kardiol; 1990; 79 Suppl 3():89-98. PubMed ID: 1983054
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacology of multiple action compounds.
Prichard BN; Tomlinson B
Z Kardiol; 1989; 78 Suppl 3():1-6. PubMed ID: 2573211
[TBL] [Abstract][Full Text] [Related]
3. A new molecule with vasodilating and beta-adrenoceptor blocking properties.
Abshagen U
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S23-32. PubMed ID: 2454364
[TBL] [Abstract][Full Text] [Related]
4. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure.
DasGupta P; Broadhurst P; Lahiri A
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S12-6. PubMed ID: 1721973
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
Eggertsen R
Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
[TBL] [Abstract][Full Text] [Related]
6. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
Lund-Johansen P
Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive compounds with combined actions.
Rahn KH
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S18-22. PubMed ID: 2454363
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and clinical aspects of drug therapy in coronary heart disease: clinical aspects of therapy with beta-adrenoceptor antagonists.
Prichard BN
Z Kardiol; 1990; 79 Suppl 3():99-103. PubMed ID: 1983055
[TBL] [Abstract][Full Text] [Related]
9. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
Ruffolo RR; Feuerstein GZ
Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol in ischaemic heart disease.
Prichard BN
Cardiology; 1993; 82 Suppl 3():34-9. PubMed ID: 8106163
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
[TBL] [Abstract][Full Text] [Related]
13. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of carvedilol, a compound with beta-blocking and vasodilating properties.
Strein K; Sponer G; Müller-Beckmann B; Bartsch W
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S33-41. PubMed ID: 2454365
[TBL] [Abstract][Full Text] [Related]
15. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
Wendt T; van der Does R; Schräder R; Landgraf H; Kober G
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S147-50. PubMed ID: 2454362
[TBL] [Abstract][Full Text] [Related]
16. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
Das Gupta P; Broadhurst P; Raftery EB; Lahiri A
Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300
[TBL] [Abstract][Full Text] [Related]
17. Can intravenous beta-blockade predict long-term hemodynamic benefit in chronic congestive heart failure secondary to ischemic heart disease? A comparison of intravenous with oral carvedilol.
DasGupta P; Lahiri A
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S62-7. PubMed ID: 1378153
[TBL] [Abstract][Full Text] [Related]
18. [Acute hemodynamic effects of the vasodilator beta blocker carvedilol in heart failure].
Buchwald A; Unterberg C; van der Does R; Wiegand V
Z Kardiol; 1990 Jun; 79(6):424-8. PubMed ID: 1974100
[TBL] [Abstract][Full Text] [Related]
19. Beta-blocking agents with vasodilating action.
Prichard BN
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S1-4. PubMed ID: 1378133
[TBL] [Abstract][Full Text] [Related]
20. Effects of carvedilol on left ventricular function and arrhythmias during repeated short-time myocardial ischemia in experimental pigs.
Höher M; Friedrich M; Sommer T; Marten A; Ehmer B; Hombach V; Hirche H
Z Kardiol; 1989; 78 Suppl 3():7-15. PubMed ID: 2573214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]